Founded as CapMinder with an exclusive focus on developing intellectual property to real time monitor and measure the consumption of prescription medication taken by patients. The result of years research, numerous issued patents and the ever growing opioid epidemic surrounding opioid abuse serve as the catalyst behind aggressively commercializing these efforts under the iScRipt brand. iScRipt™ is developing a surveillance ecosystem of patented intelligent devices, smart pill bottles, networked software, and cloud services generating timely, accurate, actionable data and insights to help effectively respond to the opioid epidemic. Data helps manufacturers, distributors, insurers, doctors, pharmacists, and patients understand the extent of the opioid crisis, proactively focus resources where they are needed most, and evaluate the success of prevention and response efforts. Specifically, this information identifies actual consumption and use patterns, to proactively detect misuse, abuse, and illicit disbursement. This allows for intervention early, and ultimately reduces the risk of opioid addiction and overdose before it occurs, reducing the number of naïve and unintentional addictions.